Scientists hope that the test will improve the accuracy of early Alzheimer’s diagnostics and aid the selection of candidates who are likely to benefit from preemptive therapeutic interventions.
Scientists from the University of Pittsburgh School of Medicine have made a groundbreaking discovery about Alzheimer's disease. Their research suggests
A study by the University of Pittsburgh suggests the build-up of amyloid in the brain is not enough to determine who ll develop Alzheimer s. The combination of plaque and blood markers are key.
Why do some people develop Alzheimer's disease while others don't? And, even more puzzlingly, why do many individuals whose brains are chock-full of toxic amyloid aggregates-;a telltale sign of Alzheimer's brain pathology-;never go on to develop Alzheimer's-associated dementias?